news
Scmp World
2026-07-16
Mainland China Funds Boost Stakes in Hong Kong Biotech Amid Licensing Surge
Mainland Chinese institutional investors are increasing their holdings in Hong Kong-listed biotech firms, attracted by favorable valuations and a rise in cross-border licensing deals.